http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2013011127-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c4aea92b44857b783887e33c406d2bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_848fb9fdc31ba68ea7add4f741982e26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eeb638dca33213df08758a6d11bba24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad05ad86a1e569096c38572e09797919
publicationDate 2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2013011127-A
titleOfInvention HCV TREATMENT SELECTION.
abstract The present invention is based on the discovery of an association between the SNP genotype at the rs12979860 site in the IL28B gene promoter and the likelihood of achieving SVR in patients infected with HCV who are given a triple therapy treatment containing peginterferone alfa- 2a, ribavirin, and an HCV NS5B polymerase inhibitor.
priorityDate 2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542

Total number of triples: 30.